Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 60, Issue 6B, Pages E87-E95
Publisher
Wiley
Online
2012-03-23
DOI
10.1111/j.1365-2559.2012.04195.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters
- (2011) Junlin Li et al. BMC CANCER
- The Role of Stromal Factors in Breast Tumorigenicity
- (2010) Danh Tran-Thanh et al. AMERICAN JOURNAL OF PATHOLOGY
- Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)
- (2010) F. T. Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes
- (2010) Jonas Fuxe et al. CELL CYCLE
- Emergence of the Phosphoinositide 3-Kinase-Akt- Mammalian Target of Rapamycin Axis in Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition
- (2010) Samy Lamouille et al. CELLS TISSUES ORGANS
- ErbB/EGF Signaling and EMT in Mammary Development and Breast Cancer
- (2010) Katharine M. Hardy et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
- (2010) Tony Blick et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
- (2010) Chad J. Creighton et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression
- (2010) Douglas S. Micalizzi et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
- (2010) Sunil Badve et al. MODERN PATHOLOGY
- Heregulin-β1 promotes metastasis of breast cancer cell line SKBR3 through upregulation of Snail and induction of epithelial-mesenchymal transition
- (2009) LianSheng Cheng et al. CANCER LETTERS
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On
- (2009) Harikrishna Nakshatri et al. Current Stem Cell Research & Therapy
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Epithelial-Mesenchymal Transition and the Stem Cell Phenotype
- (2008) Derek C. Radisky et al. Cell Stem Cell
- Epithelial mesenchymal transition traits in human breast cancer cell lines
- (2008) T. Blick et al. CLINICAL & EXPERIMENTAL METASTASIS
- Epithelial-Mesenchymal Transition in Cervical Cancer: Correlation with Tumor Progression, Epidermal Growth Factor Receptor Overexpression, and Snail Up-Regulation
- (2008) M.-Y. Lee et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer
- (2008) Anna Bergamaschi et al. Molecular Oncology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started